GCRI · Technology
Biotechnology platforms
Biotechnology platforms apply biological systems to produce medicines, diagnostics, materials and agricultural products. They expand response capacity for health threats while introducing dual-use and biosafety concerns. Biotechnology and Biosecurity stewards this page for the Nexus Consortium.
01Register
Biotechnology platforms on the record.
The Global Centre for Risk and Innovation
- 01InstitutionThe Global Centre for Risk and Innovation (GCRI)
- 02The methodWhat biotechnology platforms covers
- 03Reference practiceBiotechnology is governed by biosafety, biosecurity and responsible-use frameworks
- 04In systemic risk workPlatform capacity is preparedness
- 05Applied inPlatforms that apply this method
- 06StewardshipWho maintains this page
- 07SourcesWhere this page’s references lead
02The method
What biotechnology platforms covers.
- 01
Core methods
genetic engineering; bioprocess design; high-throughput screening; diagnostic assay development; vaccine platform development; biosafety risk assessment.
- 02
Data and instruments
laboratory automation systems; bioreactor process data; clinical trial registries; genomic databases; manufacturing quality records.
- 03
Validation
Products are evaluated through staged preclinical and clinical testing and manufacturing quality controls. Regulatory review and independent replication check claims.
- 04
Limits
Scale-up from laboratory to production often fails or takes time. Containment and oversight can lag behind technical capability.
- 05
Use in risk decisions
Biotechnology capacity shapes how quickly countermeasures can be produced in a crisis. Its supply chains and dual-use potential are part of biosecurity planning.
03Reference practice
Biotechnology is governed by biosafety, biosecurity and responsible-use frameworks.
| Reference | What it sets |
|---|---|
| WHO Laboratory Biosafety Manual | Risk-based biosafety |
| WHO responsible life sciences framework | Dual-use governance |
| Cartagena Protocol | Living modified organisms |
| Biological Weapons Convention | Prohibition and confidence-building measures |
This page covers capacity and oversight only.
04Process
How the process runs.
Process
Biotechnology platforms: Life-science research oversight
Capacity and oversight only, following the WHO Laboratory biosafety manual (4th edition) and WHO life sciences framework, with no methods, agents or protocols.
01 Institution
- 01ProposalDatasetA research institution submits a proposal for review. The place is set by the page.
- 02Institutional committeeGate · The institutionA biosafety committee is an independent institutional review group, reporting to senior management. Review follows national rules.
- 03Conditions: risk control measuresStepA risk assessment sets the measures: core requirements, heightened control measures or maximum containment, not one biosafety level.
- 04Training and competenceStepActual risk depends on the agent, the procedure and staff competency. Training and personnel competence have their own section.
02 Assurance
- 05Audit and inspectionGateMany labs run cooperative inspections: periodic self-audits plus a rarer, deeper evaluation with the biosafety officer or committee.
- 06Emergency and incident responseStepThe manual covers emergency and incident response at each level of measures. External reporting of incidents depends on national rules.
03 National
- 07National oversightDecision · Independent reviewerThe WHO framework is for those who govern biorisks, such as policy makers and regulators. National bodies set national rules.
Neutral outline of a published external standard or method, from its issuing body. Not a record of operation. Nexus does not perform, certify or approve any step shown. A gate or decision belongs to the party the source names. The Biological Weapons Convention is not drawn in this flow. The framework is the WHO global guidance framework for the responsible use of the life sciences.
05In systemic risk work
Platform capacity is preparedness.
Biotechnology platforms (diagnostics, vaccine and therapeutic manufacturing) determine how quickly countries can respond to outbreaks and crop diseases. Systemic analysis looks at geographic concentration of capacity and at oversight arrangements, not at laboratory methods.
- Map manufacturing concentration for countermeasures.
- Assess regulatory reliance arrangements that speed approvals.
- Review oversight capacity alongside research capacity.
- Oversight work sits on Biotechnology and Biosecurity.
06Applied in
Platforms that apply this method.
07Stewardship
Who maintains this page.
Biotechnology and Biosecurity stewards biotechnology platforms: it keeps this description current and reviews how the method is applied across the platforms.
08Sources
Where this page’s references lead.
The bodies and documents this page is read against. Status and editions change; each link goes to the issuing body.
09Questions
Questions and answers.
Why does one institution host every method page?
GCRI hosts the STEM Commons so that each method has one canonical description. Platforms link to it rather than repeat it, which keeps definitions consistent.
How do I suggest a correction to a method page?
Write to the integrity concern form with the passage and the reason.
ReportsContribute
Contribute evidence from this page.
Reports is the Consortium’s quarterly publication. What you know about this subject can become evidence, a case or a correction in the next edition, credited to you and published under CC BY 4.0 where it is your own work.
GCRI
- EmailGateway GW-GCRISend it from this pageEvidence, a correction, a case, a method, a review, a translation or profile input. It arrives tagged with this page, so the editor who owns it receives it.
- ZenodoOpen depositDeposit it and submit to the communityPublish your own record on Zenodo with your ORCID iD, then submit it to the Reports community there. Curators review it; the DOI stays yours.
- ReportsGCRISee every way to contributeThe contribution types, how each is reviewed, what credit you receive, the licence and what is never accepted.
Never send personal data, sensitive infrastructure detail or anything you have no right to share. A contribution is reviewed before use; sending it confers no authorship or editorial rights, and sponsorship never buys a finding.
The Global Centre for Risk and Innovation
Bring a method, a dataset or a question.
Information and enquiries are open today. An enquiry receives a reference and names the next step; applications, payments, compute allocations and registrations open only when their team, terms and review capacity exist.
Legal
Legal documents.
Maps, data and figures on this site are shown for context and general information. They are not advice, forecasts or warnings; the limits of the information are set out in the Disclaimers and Data Notices.